Abstract
Background
Hepatitis B virus (HBV) is one of the most prevalent chronic viral infections that causes chronic hepatitis B (CHB). In Japan, genotypes B and C account for most of acute and chronic cases of hepatitis. However, previous studies showed that the prevalence of genotype A in CHB gradually increased every 5 years. Therefore, we have conducted a nationwide survey to comprehensively investigate the trends of HBV genotype distribution in CHB patients in Japan.
Methods
4421 CHB patients were recruited between 2015 and 2016. Clinical characteristics and distribution of CHB patients among different age groups and genotypes in 2015–2016 was compared with those in 2000–2001, 2005–2006, and 2010–2011.
Results
The percentages of genotype A, B, C, and D were 4.0, 16.2, 79.1, and 0.7%, respectively. While the overall percentage of CHB patients with genotype A did not change in the past 5 years, CHB with genotype A increased in young adults. On the other hand, the peak distribution of CHB with genotypes B and C, two genotypes with the largest patient population, has shifted to an older age group.
Conclusions
In Japan, the peak distribution for CHB with genotypes B and C advanced to an older age group while CHB with genotype A expanded in a younger age group. Given the universal HBV vaccination launch in Japan in 2016, these pre-vaccination survey data provide important baseline information for comparative studies of the impact of universal vaccination on HBV genotypes.
Similar content being viewed by others
Abbreviations
- HBV:
-
Hepatitis B virus
- HBsAg:
-
Hepatitis B surface antigen
- AHB:
-
Acute hepatitis B
- HBeAg:
-
Hepatitis B-e antigen
- CHB:
-
Chronic hepatitis B
- HCC:
-
Hepatocellular carcinoma
- CT:
-
Computerized tomography
- MRI:
-
Magnetic resonance imaging
- EIA:
-
Enzyme immunoassay
- HIV:
-
Human immunodeficiency virus
References
Okamoto H, Tsuda F, Sakugawa H, et al. Typing hepatitis B virus by homology in nucleotide sequence: comparison of surface antigen subtypes. J Gen Virol. 1988;69:2575–83.
Norder H, Hammas B, Lofdahl S, et al. Comparison of the amino acid sequences of nine different serotypes of hepatitis B surface antigen and genomic classification of the corresponding hepatitis B virus strains. J Gen Virol. 1992;73:1201–8.
Orito E, Ichida T, Sakugawa H, et al. Geographic distribution of hepatitis B virus (HBV) genotype in patients with chronic HBV infection in Japan. Hepatology. 2001;34:590–4.
Miyakawa Y, Mizokami M. Classifying hepatitis B virus genotypes. Intervirology. 2003;46:329–38.
Norder H, Couroucé AM, Coursaget P, et al. Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes. Intervirology. 2004;47:289–309.
Kurbanov F, Tanaka Y, Mizokami M. Geographical and genetic diversity of the human hepatitis B virus. Hepatol Res. 2010;40:14–30.
Kao JH. Hepatitis B viral genotypes: clinical relevance and molecular characteristics. J Gastroenterol Hepatol. 2002;17:643–50.
Suzuki Y, Kobayashi M, Ikeda K, et al. Persistence of acute infection with hepatitis B virus genotype A and treatment in Japan. J Med Virol. 2005;76:33–9.
Ito K, Yotsuyanagi H, Sugiyama M, et al. Geographic distribution and characteristics of genotype A hepatitis B virus infection in acute and chronic hepatitis B patients in Japan. J Gastroenterol Hepatol. 2016;31:180–9.
Ito K, Yotsuyanagi H, Yatsuhashi H, et al. Risk factors for long-term persistence of serum hepatitis B surface antigen following acute hepatitis B virus infection in Japanese adults. Hepatology. 2014;59:89–97.
Ito K, Yoneda M, Sakamoto K, et al. Virological and clinical characteristics of hepatitis B virus genotype A. J Gastroenterol. 2018;53:18–26.
Sugiyama M, Tanaka Y, Kato T, et al. Influence of hepatitis B virus genotypes on the intra- and extracellular expression of viral DNA and antigens. Hepatology. 2006;44:915–24.
Ito K, Kim KH, Lok AS, et al. Characterization of genotype-specific carboxyl-terminal cleavage sites of hepatitis B virus e antigen precursor and identification of furin as the candidate enzyme. J Virol. 2009;83:3507–17.
Progress in hepatitis B prevention through universal infant vaccination--China, 1997–2006. MMWR Morbidity and mortality weekly report. 2007;56:441–5.
Matsuura K, Tanaka Y, Hige S, et al. Distribution of hepatitis B virus genotypes among patients with chronic infection in Japan shifting toward an increase of genotype A. J Clin Microbiol. 2009;47:1476–83.
Usuda S, Okamoto H, Iwanari H, et al. Serological detection of hepatitis B virus genotypes by ELISA with monoclonal antibodies to type-specific epitopes in the preS2-region product. J Virol Methods. 1999;80:97–112.
Ito K, Tanaka Y, Kato M, et al. Comparison of complete sequences of hepatitis B virus genotype C between inactive carriers and hepatocellular carcinoma patients before and after seroconversion. J Gastroenterol. 2007;42:837–44.
Horai S, Murayama K, Hayasaka K, et al. mtDNA polymorphism in East Asian populations, with special reference to the peopling of Japan. Am J Hum Genet. 1996;59:579–90.
Michitaka K, Tanaka Y, Horiike N, et al. Tracing the history of hepatitis B virus genotype D in western Japan. J Med Virol. 2006;78:44–52.
Ito K. Trends and molecular biological analysis of hepatitis B virus genotype distribution (Japanese). Research result report for Grants-in Aid for Scientific Research. 2018:1–5.
Shiraki K. Vertical Transmission of Hepatitis B Virus and its Prevention in Japan. Tokyo Japan: Springer; 1994.
Noto H, Terao T, Ryou S, et al. Combined passive and active immunoprophylaxis for preventing perinatal transmission of the hepatitis B virus carrier state in Shizuoka, Japan during 1980–1994. J Gastroenterol Hepatol. 2003;18:943–9.
Koyama T, Matsuda I, Sato S, et al. Prevention of perinatal hepatitis B virus transmission by combined passive-active immunoprophylaxis in Iwate, Japan (1981–1992) and epidemiological evidence for its efficacy. Hepatol Res. 2003;26:287–92.
World Health O. Weekly epidemiological record. . [full issue]. 2009;84(40):405–20.
Buster EH, Hansen BE, Lau GK, et al. Factors that predict response of patients with hepatitis B e antigen-positive chronic hepatitis B to peginterferon-alfa. Gastroenterology. 2009;137:2002–9.
Funding
This work was supported by “AMED Program on the Innovative Development and the Application of New Drugs for Hepatitis B under Grant Number JP20fk0310118, JP21fk0310118h0005 and JP22fk0310502h0001,” “The Japanese Society of Gastroenterology Grant,” and “JSPS KAKENHI Grant Number JP19K08479”.
Author information
Authors and Affiliations
Contributions
KS and KI: designed the research study and contributed to the interpretation of data and wrote the manuscript. HY, HY, YT, YK, YT, YU, KY, FI, JI, MK, TU, HT, EM, KM, TM, NY, AS, MK, YS, KM, AO, YF and MS: contributed to data collection. MM and MY: supervised the writing of the manuscript. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
KI and MY received research funding from AbbVie, Bayer Pharma, EA pharma, Otsuka Pharmaceutical, and Sumitomo Pharmaceutical. JI received research funding from AbbVie. YT received honorariums from FUJIREBIO inc., Gilead Sciences Inc, and GlaxoSmithKline PLC. YT also received research funding from FUJIFILM Corporation, Janssen Pharmaceutical K. K., Gilead Sciences Inc, Board of Trustees of the Leland, Stanford Junior University, GlaxoSmithKline PLC., FUJIREBIO inc., Sysmex Corp. YU received honorariums from Gilead Sciences and AbbVie Inc. YU also received research funding from AbbVie Inc. MK received honorariums from Gilead Sciences, AbbVie, Chugai, Eisai, Bayer, Lilly, and Otsuka. TU received honorariums from AbbVie and also received research funding from AbbVie and Tosoh Corporation. TM received research funding from IQVIA solutions. MY received honorariums from Otsuka pharmaceutical and Sumitomo pharmaceutical.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Sakamoto, K., Ito, K., Yotsuyanagi, H. et al. Trends of hepatitis B virus genotype distribution in chronic hepatitis B patients in Japan. J Gastroenterol 57, 971–980 (2022). https://doi.org/10.1007/s00535-022-01921-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00535-022-01921-4